EQT, a global investment organization, agreed to acquire Life Sciences Partners, a European life sciences venture capital firm, for $516m. "EQT has a long history of developing strong healthcare companies, and today we are one of the largest and most active private equity investors in the sector globally. Integrating LSP within EQT’s Private Capital platform will bring compelling cross-pollination opportunities for our other strategies and complement our sector expertise – making EQT an even better and more innovative healthcare investor," Per Franzén, EQT Partner and Head of Private Capital.